IH vs NAMI
iHuman Inc. and Jinxin Technology Holding Co., side by side — 4 fiscal years reported in CNY, drawn from SEC filings.
Most recent reported year
| Metric | IH | NAMI |
|---|---|---|
| Revenue | CNY 807.0M | CNY 413.0M |
| Net income | CNY 95.4M | CNY -94.3M |
| Gross margin | 67.9% | 11.0% |
| Net margin | 11.8% | −24.4% |
| Return on equity | 9.8% | −87.4% |
| Diluted EPS | CNY 0.36 | −CNY 0.07 |
| Dividend / share | · | · |
| Payout ratio | 41.0% | · |
| Free cash flow | CNY 46.4M | CNY -25.4M |
| Equity | CNY 995.2M | CNY 83.9M |
| Net debt / equity | · | −0.59× |
| Current ratio | 3.57× | 1.53× |
| Revenue CAGR 5y | 8.7% | · |
| Profit CAGR 5y | · | · |
IH bills 2.0× the revenue of NAMI, and NAMI closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
4 years side by side
| Fiscal year | IH | NAMI |
|---|---|---|
| FY2025 | CNY 807.0M | CNY 413.0M |
| FY2024 | CNY 922.2M | CNY 406.4M |
| FY2023 | CNY 1.0B | CNY 379.8M |
| FY2022 | CNY 985.5M | CNY 236.4M |
Bottom line
| Fiscal year | IH | NAMI |
|---|---|---|
| FY2025 | CNY 95.4M | CNY -94.3M |
| FY2024 | CNY 98.6M | CNY 20.3M |
| FY2023 | CNY 180.9M | CNY 70.5M |
| FY2022 | CNY 109.8M | CNY 52.8M |
Standard deviation, each side
NAMI's net margin has been more volatile than IH's over the 4 comparable fiscal years — 19.2 percentage points of standard deviation against 2.9.
4 of 8 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between IH and NAMI over these 4 fiscal years — IH led in 2 and NAMI in 2.
4 of 8 comparable fiscal years — a year missing data on either side is not counted.